Danijela Jovanovic

Dr. Danijela Jovanovic

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2025 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
DPDamnjan Pantic
Damnjan Pantic
NMNikola Mirkovic
Nikola Mirkovic
TVTatjana Vulovic
Tatjana Vulovic
DJDanijela Jovanovic
Danijela Jovanovic
SJStefan Jakovljevic
Stefan Jakovljevic
IZIvanka Zelen
Ivanka Zelen
Introduction: Palladium (II) complexes are promising anticancer agents with potential advantages over platinum drugs. This study aimed to synthesize and characterize three new Pd(II) complexes (2a–2c) with Schiff base ligands derived from salicylic acid and amine scaffolds, and to evaluate their antitumor activity against prostate cancer cells.Methods: The Pd(II) complexes were synthesized and structurally characterized. Cytotoxicity was tested on two human prostate cancer cell lines (PC-3, DU-145) and healthy fibroblasts (MRC-5). Apoptosis induction was assessed by flow cytometry, with a focus on Bcl-2 and caspase proteins. Molecular docking was used to examine binding to the androgen receptor (AR) and apoptotic regulators (CASP3, BCL2, BAX). DNA and human serum albumin (HSA) binding were also investigated.Results: All complexes showed significant cytotoxicity. Notably, complex 2c exhibited more potent cytotoxic activity than cisplatin in prostate cancer cell lines, with lower IC50 values after 72 h exposure in DU-145 (7.1 µM vs. 8.2 µM) and PC-3 cells (8.6 µM vs. 21.9 µM), while showing reduced toxicity in normal MRC-5 cells (42.3 µM vs. 24.4 µM). Apoptosis was confirmed as the primary cytotoxic mechanism, involving the activation of Bcl-2 and caspases. Docking studies revealed that complex 2c had the strongest binding affinity to AR and apoptotic proteins, mediated by hydrogen bonds, π–π stacking, and hydrophobic interactions. DNA and HSA binding supported their biological relevance.Conclusion: Complex 2c exhibits potent anticancer activity through the induction of apoptosis and dual targeting of the AR and apoptotic pathways, making it a promising candidate for further development of anticancer drugs.

24 July 2018 in Serbian Journal of Experimental and Clinical Research
Verified
Journal Article
Open access
PDF file
DJDanijela Jovanovic
Danijela Jovanovic
DMDragan R. Milovanovic
Dragan R. Milovanovic
NJNevena Jeremic
Nevena Jeremic
TNTamara Nikolic
Tamara Nikolic
ISIsidora Stojic
Isidora Stojic
NVNatalija Dragoljub Vukovic
Natalija Dragoljub Vukovic
Study aimed to investigate relationship between oxidative stress markers and postoperative recovery in woman after abdominal hysterectomy, as well as to test the hypothesis that different analgesics differently influence redox status. The quality of recovery was evaluated with a QoR-40 questionnaire in fifty-one patients who underwent abdominal hysterectomy, preoperatively and on the 1st, 2nd, 3rd postoperative days (POD1,2,3). Blood samples were collected at baseline (T0), 3 (T1), 24 (T2), 48 (T3) and 72 (T4) hours after surgery. Oxidative stress markers concentrations (TBARS, NO2 −, H2O2, O2 − ) as well as antioxidative enzymes (SOD, CAT, and GSH) were analyzed. QoR-40 total score significantly declined on POD1 and POD2 and returned to baseline levels on POD3 (p0.05). Changes in TBARS levels from T0 to T3 were statistically significant between the study subgroups primarily due to increase of the concentrations in patients receiving paracetamol (p=0.031). Patients age, duration of surgery and cigarette smoking status showed significant influcences on and association with some oxidative stress response markers (TBARS, O2 −, CAT) (p<0.05). Women who underwent hysterectomy had significant changes of H2O2 and TBARS activity however, those changes were not associated with changes of QoR-40 total scores during recovery.

Verified
Journal Article
Open access
PDF file
DRDušan Radojević
Dušan Radojević
MBMihailo Bezmarevic
Mihailo Bezmarevic
MPMaja Pešić
Maja Pešić
BSBojan Stojanovic
Bojan Stojanovic
MSMiloš Stanković
Miloš Stanković
DJDanijela Jovanovic
Danijela Jovanovic
Short bowel syndrome (SBS) develops when the remaining intestine is unable to sustain adequate nutrient and electrolyte absorption following extensive bowel resection. The condition is characterized by malabsorption and significant fluid losses which lead to dehydration and progressive weight loss, thus promoting patient dependence on parenteral fluids or nutrition. After an initial acute phase marked by accelerated intestinal transit and gastric hypersecretion, long-term clinical outcomes are largely determined by the capacity of the remaining bowel for intestinal adaptation—a sustained process of structural, functional, and molecular remodeling that enhances absorptive efficiency and restores fluid and nutrient homeostasis. This review summarizes the key histological and cellular features of the adaptive response, including crypt and villus remodeling, mucosal hyperplasia, and smooth muscle hypertrophy, and integrates emerging concepts in crypt biology that define the dynamic cross-talk between intestinal stem cells and the mesenchymal niche, together with their upstream regulatory pathways.

1 January 2025 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
MBMihailo Bezmarevic
Mihailo Bezmarevic
IPIvan Golub Palibrk
Ivan Golub Palibrk
MSMirjana Stojsic
Mirjana Stojsic
NVNatalija Dragoljub Vukovic
Natalija Dragoljub Vukovic
MDMarija Djukanovic
Marija Djukanovic
NGNUPENS Short Bowel Syndrome Multidisciplinary Expert Group
NUPENS Short Bowel Syndrome Multidisciplinary Expert Group

15 February 2020 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
DJDanijela Jovanovic
Danijela Jovanovic
DMD. R. Milovanovic
D. R. Milovanovic
IJI. Jovanovic
I. Jovanovic
MFMarko Folic
Marko Folic
VJV. Jakovljevic
V. Jakovljevic
Purpose of Investigation: The relationships between postoperative recovery and changes of circulating levels of pro- and anti-inflammatory cytokines. Materials and Methods: The study included prospectively a cohort of 51 females who underwent abdominal hysterectomy for benign diseases. Recovery was assessed with Quality of Recovery 40 (QoR-40) questionnaire and concentrations of four cytokines during the 72-hours period were measured using human sensitive enzyme-linked immunosorbent assay (ELISA) kits. Results: Total QoR-40 score significantly declined on the first and the second postoperative days and then returned to baseline (p < 0.001). Interleukin-17 serum levels had no significant trend (p = 0.072). Statistically significant patterns of concentration changes of interferon gamma (p = 0.010), interleukin-10 (p < 0.001), and transforming growth factor (p = 0.016) were found. There were no significant correlations between QoR-40 scores and concentrations of any cytokine, at prespecified study power for moderate relationships at least. Conclusion: Recovery after abdominal hysterectomy was rapid and complete and it was unrelated to serum concentration profiles of examined cytokines.

23 May 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
APAleksandra D Petrovic
Aleksandra D Petrovic
ABAna Barjaktarevic
Ana Barjaktarevic
OKOlivera Zoran Kostic
Olivera Zoran Kostic
SMSara Mijailovic
Sara Mijailovic
SJSlobodan Janković
Slobodan Janković
MKMarina Jovica Kostic
Marina Jovica Kostic
Background/Objectives: Adverse effects of antipsychotics represent a significant limiting factor in achieving favorable therapeutic outcomes in the treatment of schizophrenia, and may contribute to a diminished quality of life among affected individuals. The primary objective of this study was to identify and evaluate the adverse effects of antipsychotics in patients diagnosed with schizophrenia who were treated at the social welfare institution, as well as to analyze the impact of these adverse effects on patients’ overall quality of life. Methods: A clinical, observational cross-sectional study was conducted, involving a sample of 278 patients diagnosed with schizophrenia. The patients were assessed in terms of their sociodemographic and clinical characteristics. Adverse effects of antipsychotics were evaluated using The Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale, while quality of life was assessed in the previous study. Results: The average number of adverse effects per patient with schizophrenia was 3.56 for psychiatric, 1.18 for neurological, 2.62 for autonomic, and 7.12 for other side effects. The average UKU score was 17.22 ± 11.04, with significant differences based on accommodation, antipsychotic type, and dosing regimen. UKU scores were negatively correlated with the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) index, Visual Analog Scale (VAS) score, the Quality-of-Life Enjoyment and Satisfaction Questionnaire—Short Form (Q-LES-Q-SF) score, and the scores of physical and psychological domains of the World Health Organization Quality-of-Life Scale (WHOQOL-BREF). Conclusions: The findings of this study suggest that the presence of antipsychotic-related adverse effects is a significant determinant that can negatively influence the quality of life in patients with schizophrenia. These results underscore the importance of an individualized approach when determining pharmacological treatment strategies in the management of schizophrenia.